We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEYE icon
5676
AudioEye
AEYE
$72.3M
$32K ﹤0.01%
+3,150
New +$24K
ALLT icon
5677
Allot
ALLT
$372M
$32K ﹤0.01%
3,055
-6,747
-69% -$71.5K
BBCP icon
5678
Concrete Pumping Holdings
BBCP
$490M
$32K ﹤0.01%
9,292
+6,242
+205% +$19K
DJD icon
5679
Invesco Dow Jones Industrial Average Dividend ETF
DJD
$482M
$32K ﹤0.01%
966
+852
+747% +$28.2K
FLCH icon
5680
Franklin FTSE China ETF
FLCH
$288M
$32K ﹤0.01%
1,252
MBOT icon
5681
Microbot Medical
MBOT
$116M
$32K ﹤0.01%
4,663
-13,858
-75% -$93.8K
NEPH icon
5682
Nephros
NEPH
$36.8M
$32K ﹤0.01%
3,815
TWN
5683
Taiwan Fund
TWN
$471M
$32K ﹤0.01%
1,501
ABTC
5684
American Bitcoin Corp
ABTC
$403M
0
GRCE
5685
Grace Therapeutics
GRCE
$33.8M
$32K ﹤0.01%
1,416
-1,934
-58% -$56.4K
TCS
5686
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$32K ﹤0.01%
655
+141
+27% +$5.44K
PBIP
5687
DELISTED
Prudential Bancorp, Inc.
PBIP
$32K ﹤0.01%
2,711
+2,015
+290% +$24K
ICBK
5688
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$32K ﹤0.01%
1,548
+1,261
+439% +$25.7K
OSN
5689
DELISTED
Ossen Innovation Co., Ltd.
OSN
$32K ﹤0.01%
+11,401
New +$25.1K
FTAG icon
5690
First Trust Exchange-Traded Fund II First Trust Indxx Global Agriculture ETF
FTAG
$14.3M
$31K ﹤0.01%
1,607
JILL icon
5691
J. Jill
JILL
$272M
$31K ﹤0.01%
8,725
+6,224
+249% +$16.9K
PVL
5692
Permianville Royalty Trust
PVL
$57.1M
$31K ﹤0.01%
25,906
-4,835
-16% -$6.39K
XENE icon
5693
Xenon Pharmaceuticals
XENE
$6.06B
$31K ﹤0.01%
2,499
-2,946
-54% -$37.5K
AAVM
5694
EA Series Trust Alpha Architect Global Factor Equity ETF
AAVM
$25.2M
$31K ﹤0.01%
1,388
CSSE
5695
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$31K ﹤0.01%
4,500
+500
+13% +$3.89K
PGAL
5696
DELISTED
Global X MSCI Portugal ETF
PGAL
$31K ﹤0.01%
3,295
CBMB
5697
DELISTED
CBM Bancorp, Inc.
CBMB
$31K ﹤0.01%
2,500
+2,390
+2,173% +$28.6K
AXAS
5698
DELISTED
Abraxas Petroleum Corp
AXAS
$31K ﹤0.01%
6,778
+1,012
+18% +$4.58K
NAVB
5699
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$31K ﹤0.01%
7,750
EGLE
5700
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$31K ﹤0.01%
2,028
+1,510
+292% +$20.3K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.